The first parliamentary debate on the economic benefits of the UK medical cannabis industry was welcomed this week, but garnered a ‘predictably poor’ response from government. A number of cross-party MPs spoke up in support of the UK’s medical cannabis industry in parliament’s first debate on [...]
New white label CBD food products are back – the UK’s largest independently owned, producer, and distributor has launched a range of CBD products and ingredients that brings innovation back to the sector in a post-novel foods world. BRITISH CANNABIS unveils its Non-Novel CBD Supplements range [...]
Researchers in Australia have received funding for a world-first clinical trial into medicinal cannabis and endometriosis. Researchers at Western Sydney University have received a grant of $660,000 for a three year study of medicinal cannabis as a potential treatment for endometriosis. The grant will fund a [...]
The post The Cannabis Quality Conference appeared first on Cannabis Industry Journal.
ASTM International has announced the approval of a new standard in development that could have potentially wide-reaching influence on the cannabis industry throughout the world. ASTM’s cannabis committee (D37) has approved the new standard (D8449) for development that aims to develop internationally aligned label specifications for [...]
Copyright © 2024 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
